CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $340,397
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$340,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-06-22 | RITTER DALE SVP & Chief Accounting Officer | Purchase | +5,000 | $5.00 | $25K | 10,000 |
| 2012-02-22 | RITTER DALE SVP & Chief Accounting Officer | Grant or award · Options to purchase Common Stock | +30,000 | 30,000 | ||
| 2012-02-10 | ROSENWALD LINDSAY A MD Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2012-02-10 | COOPER GLENN L MD Director | Grant or award · Options to purchase Common Stock | +45,000 | 45,000 | ||
| 2012-02-10 | Rowinsky Eric K Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2012-02-10 | LOBELL J JAY Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2012-02-10 | Harvey Jimmie Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2012-02-10 | ROGERS MICHAEL W Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2012-02-10 | BARRETT DAVID JONATHAN Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2012-01-23 | ROSENWALD LINDSAY A MD President and CEO | Purchase | +2,000 | $6.95 | $14K | 2,461,001 |
| 2012-01-23 | ROSENWALD LINDSAY A MD Director | Purchase | +2,000 | $6.95 | $14K | 2,459,001 |
| 2012-01-23 | ROSENWALD LINDSAY A MD Director | Purchase | +2,000 | $6.95 | $14K | 2,425,632 |
| 2012-01-20 | ROSENWALD LINDSAY A MD Director | Purchase | +2,000 | $5.66 | $11K | 2,423,632 |
| 2012-01-19 | ROSENWALD LINDSAY A MD Director | Purchase | +2,000 | $5.67 | $11K | 2,421,632 |
| 2012-01-18 | ROSENWALD LINDSAY A MD Director | Purchase | +2,000 | $5.66 | $11K | 2,419,632 |
| 2012-01-17 | ROSENWALD LINDSAY A MD Director | Purchase | +2,000 | $5.40 | $11K | 2,417,632 |
| 2012-01-13 | ROSENWALD LINDSAY A MD Director | Purchase | +2,000 | $5.40 | $11K | 2,415,632 |
| 2012-01-12 | Beerman Noah D | Purchase | +5,000 | $4.99 | $25K | 5,000 |
| 2012-01-12 | SANDAGE BOBBY W PHD President and CEO | Purchase | +1,000 | $5.20 | $5K | 1,500 |
| 2012-01-12 | ROSENWALD LINDSAY A MD Director | Purchase | +2,000 | $5.20 | $10K | 2,413,632 |
Page 14 of 15 · 297 trades